Travel Medicine Update

Icahn School of Medicine at Mount Sinai

D. Caplivski

Nirsevimab for RSV: A Breakthrough Product for Babies

MicrobeTV

P. Offit, V. Racaniello

IDWeek 2024 Insights: To Mask or Not to Mask - Approaches to Source …

IDWeek 2024 Insights

E. Landon

Hydrocortisone Reduces Mortality by 48% in Severe Community-Acquired…

MedCram

R. Seheult

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Underst…

Jaime Seltzer

What to Know About the FDA Authorization and Approval of Updated COV…

Amesh Adalja

Anal Cancer: Risk Factors and Prevention

GRACE

P. Romesser

Project 2025 vs. the Public's Health Part II: The FDA

MicrobeTV

P. Offit, V. Racaniello

The Durability of the Antibody Response Following Monkeypox Vaccinat…

MicrobeTV

D. Griffin, V. Racaniello

Top Risk Factors for Cancer by Sex and What to Do About It

MedCram

R. Seheult

What's Hot (Not) in (HIV) Primary Care

UCSF School of Medicine

C. Bositis, J. Bloome

CHEST 2024 Insights: Vaccination Challenges and Strategies for Viral…

CHEST Annual Meeting Insights

A. Kapoor

Newly Licensed Respiratory Syncytial Virus Vaccines for Adults: What…

MicrobeTV

P. Offit, V. Racaniello

Understanding Changes in Acute Care and Mortality Patterns Among Chi…

Christina Belza

Preventing Complications with Vaccines in Persons with Diabetes (PWD)

Allison Presnell

Focusing on Flow: PSA Screening in PWH

UCSF School of Medicine

H. Patel

Monkeypox Declared a Public Health Emergency of International Concer…

MicrobeTV

D. Griffin, V. Racaniello

Long COVID and ME/CFS: Are They the Same Condition?

Charles Shepherd

Durability of Protection Following Administration of Recombinant Ant…

MicrobeTV

D. Griffin, V. Racaniello

H5N1 Outbreak: Are We Inching Closer to Human Transmissibility?

MedCram

R. Seheult